Biomarkers and Diagnostics

Biomarkers and Diagnostics assesses the technical and market environment for the development and use of biomarkers and diagnostic tests. Focusing on opportunities, challenges, and trends, we provide high-level insight into the major drivers and pitfalls of biomarker-based R&D and diagnostic marketplaces. These reports help you understand how novel technologies can best fit into your drug and/or diagnostic development strategy and identify potential collaboration opportunities so that you can put that strategy into action.

Our most recent Biomarkers and Diagnostics reports:

Noninvasive Approaches Offer Substantial Market Potential in Liver Disease Diagnostics

The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends

Emerging Diagnostic Technologies for Use in Psychiatric Indications

Blood Biomarkers and Beyond: Biomarker and Diagnostic Opportunities in Cardiovascular Disease

Harnessing Biomarker Research in Academic Institutions for Use in Industry